Education
About Us
Working with TipRanks
Follow Us
Zura Bio (ZURA)
NASDAQ:ZURA
Total Valuation
Zura Bio has a market cap or net worth of $76.58M. The enterprise value is -$50.17K.
Market Cap$76.58M
Enterprise Value-$50.17K
Share Statistics
Zura Bio has 68.38M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68.38M
Owned by Insiders7.83%
Owned by Instutions46.12%
Financial Efficiency
Zura Bio’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -29.87%.
Return on Equity (ROE)-30.91%
Return on Assets (ROA)-25.28%
Return on Invested Capital (ROIC)-29.87%
Return on Capital Employed (ROCE)-34.49%
Revenue Per Employee$0
Profits Per Employee-$1,590,766.667
Employee Count30
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zura Bio is -4.14. Zura Bio’s PEG ratio is 0.06.
PE Ratio-4.14
PS Ratio0.00
PB Ratio1.28
Price to Fair Value1.28
Price to FCF-6.67
Price to Operating Cash Flow-6.68
PEG Ratio0.06
Income Statement
In the last 12 months, Zura Bio had revenue of $0.00 and earned -$47.72M in profits. Earnings per share was $0.03.
Revenue$0.00
Gross Profit$0.00
Operating Income-$55.19M
Pretax Income-$52.40M
Net Income-$47.72M
EBITDA-55.18M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was -$28.08M and capital expenditures -$75.00K, giving a free cash flow of -$28.15M billion.
Operating Cash Flow-$28.08M
Free Cash Flow-$28.15M
Free Cash Flow per Share-$0.41
Dividends & Yields
Zura Bio pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-15.00%
Earnings Yield-24.18%
Stock Price Statistics
Beta1.51
52-Week Price Change-63.16%
50-Day Moving Average1.33
200-Day Moving Average2.90
Relative Strength Index (RSI)43.28
Average Volume (3m)347.19K
Important Dates
Zura Bio upcoming earnings date is May 8, 2025, Before Open.
Last Earnings DateMar 25, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Zura Bio as a current ratio of 9.16, with Debt / Equity ratio of 0.00
Current Ratio9.16
Quick Ratio9.16
Debt to Market Cap0.00
Net Debt to EBITDA3.20
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zura Bio has paid -$3.65M in taxes.
Income Tax-$3.65M
Effective Tax Rate13.39%
Enterprise Valuation
Zura Bio EV to EBITDA ratio is -0.20, with an EV/FCF ratio of -0.40.
EV to Sales0.00
EV to EBITDA-0.20
EV to Free Cash Flow-0.40
EV to Operating Cash Flow-0.40
Balance Sheet
Zura Bio has $176.50M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$176.50M billion.
Cash & Marketable Securities$176.50M
Total Debt$0.00
Net Cash-$176.50M
Net Cash Per Share-$2.58
Tangible Book Value Per Share$2.13
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Zura Bio is $11.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$11.80
Price Target Upside953.57%
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast
EPS Growth Forecast86.65%